Winter COVID booster for at-risk groups, Vic to make mRNA vaccines
25 March, 2022ATAGI recommends an additional booster dose of COVID-19 vaccine for vulnerable population groups, and Moderna agrees to produce up to 100 million Australian-made mRNA vaccine doses every year.
CRISPR cancer therapy doesn't kill healthy cells
14 March, 2022Researchers have combined the concepts of cancer genomics and CRISPR-Cas9 to propose a cancer therapy that kills cancer cells without affecting normal tissues.
HEK cells vs CHO cells: what's the better choice?
07 March, 2022Due to the many possibilities as well as advantages and disadvantages, it can be quite troubling to decide which cells would serve specific research the best.
Moderna COVID-19 vaccine approved for kids 6–11
23 February, 2022The Australian Government has accepted advice to make the Moderna COVID-19 vaccine available for children aged six years and older from 24 February 2022.
More efficient method for creating sulfur-based medicines
21 February, 2022Scientists say their method gives rise to a series of sulfur-based pharmacophores with enough variation to make the drug discovery process more efficient and fruitful.
One dose of anti-parasite drug effective at reducing scabies
16 February, 2022One dose of ivermectin was not inferior to two doses, taken a week apart, for reducing scabies prevalence in Fiji.
'Bionic' pacemaker reinstates heart rate variability
09 February, 2022Researchers from The University of Auckland have designed a pacemaker that re-establishes the heart's naturally irregular beat.
Pfizer booster now available for teens 16+
03 February, 2022From 3 February, eligible Australians aged 16 and 17 years old will be able to receive a COVID-19 booster vaccine.
Lumos set to manufacture rapid antigen tests in Victoria
03 February, 2022Lumos Diagnostics has agreed to establish a manufacturing facility and innovation hub in Victoria, which will help the state to secure critical supplies of RATs.
TGA approves Novavax vaccine, oral treatments for COVID-19
21 January, 2022 by Lauren DavisThe TGA has granted provisional approval for the first two oral treatments for COVID-19 in Australia, as well as the much-anticipated Novavax vaccine.
Moderna bringing mRNA vaccine manufacturing to Victoria
15 December, 2021A sovereign onshore vaccine manufacturing facility will be built in Victoria as part of a long-term strategic partnership to increase preparedness for possible future pandemics.
Anticancer drug prevents heart damage from chemotherapy
14 December, 2021Zantrene is able to protect heart muscle cells from death, while improving the killing of breast cancer cells, when used in combination with the anthracycline known as doxorubicin.
Pfizer and Moderna boosters now available from five months
13 December, 2021Australian adults can now receive a Moderna or Pfizer COVID-19 booster shot after five months, while Pfizer primary doses will be available to children aged 5–11.
TGA approves booster doses of Moderna vaccine
09 December, 2021The TGA has provisionally approved a booster dose of the Moderna COVID-19 vaccine for individuals 18 years and older, as well as a monoclonal antibody treatment.
TGA provisionally approves Pfizer vaccine for children
06 December, 2021Subject to final recommendations from ATAGI, the Australian Government will start rolling out the Pfizer vaccine to 5- to 11-year-olds from 10 January 2022.
